IBS-624

N/A

Report date: 2023/03/12 14:49:25
NME

Base Information

Drug NameIBS-624
Drug Alias NameIBS-624
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLiver X receptor agonists
TargetsLiver X receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntegral Biosciences Pvt Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A